7Baggers

CASI Pharmaceuticals Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20150331 20150630 20151231 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 -18.66-13.6-8.53-3.471.66.6611.7316.79Milllion

CASI Pharmaceuticals Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2015-12-31 2015-06-30 2015-03-31 2014-12-31 2012-12-31 2011-12-31 2011-06-30 2010-12-31 2009-12-31 2009-09-30 2008-12-31 2008-09-30 2007-12-31 2007-09-30 2006-12-31 2006-09-30 2005-12-31 2005-09-30 2005-06-30 2005-03-31 2004-12-31 2004-09-30 2004-06-30 2004-03-31 2003-12-31 2003-09-30 2003-06-30 2003-03-31 2002-12-31 2002-09-30 2002-06-30 2002-03-31 2001-12-31 2001-09-30 2001-06-30 2001-03-31 2000-12-31 2000-09-30 2000-06-30 2000-03-31 1999-12-31 1999-09-30 1999-06-30 1999-03-31 1998-12-31 1998-09-30 1998-06-30 1998-03-31 1997-12-31 1997-09-30 1997-06-30 1997-03-31 1996-12-31 1996-09-30 1996-06-30 1996-03-31 1995-12-31 1995-09-30 1995-06-30 
  revenue8,838,000 9,820,000 8,347,000 15,259,000 10,213,000 8,573,000 9,062,000 9,158,000 8,112,000 7,162,000 5,736,000 4,822,000 4,242,000 2,671,000 3,406,000 1,344,000 2,787,000 5,422 23,994 23,718 23,727 669,310 1,932,035 8,852 3,693,167 1,615,725 3,668,333 3,975,912 3,501,307 3,875,392 3,520,259 3,871,173 3,023,185 4,063,745 1,249,600 579,461 25,249 133,911 142,738 139,380 97,967 517,533 258,478 285,988 513,547 461,821 345,569 309,170 59,930 129,478 90,988 757,523 883,952 1,223,965 854,170 866,941 726,699 400,000 1,800,000 1,300,000 1,400,000 1,500,000 1,300,000 1,200,000 1,200,000 1,400,000 1,200,000 1,100,000 1,100,000 1,100,000 1,100,000 1,100,000 1,100,000 580,000 50,000 90,000 
  cost of revenue3,648,000 3,986,000 3,378,000 4,272,000 4,247,000 3,550,000 3,758,000 3,800,000 3,417,000 2,982,000 2,358,000 1,952,000 1,828,000 2,517,000 3,211,000 1,287,000 2,648,000 2,711 2,726 6,259 7,467 -316,477 -306,251 -274,959 -254,172 -242,285 -200,000 -200,000 -200,000 -300,000 -100,000 -200,000 -200,000 -200,000 -100,000 -100,000 -100,000 7,600,000 -100,000 -100,000 
  gross profit5,190,000 5,834,000 4,969,000 10,987,000 5,966,000 5,023,000 5,304,000 5,358,000 4,695,000 4,180,000 3,378,000 2,870,000 2,414,000 154,000 195,000 57,000 139,000 2,711 21,268 17,459 16,260 669,310 1,932,035 8,852 3,693,167 1,615,725 3,668,333 3,975,912 3,501,307 3,875,392 3,520,259 3,871,173 3,023,185 4,063,745 1,249,600 579,461 25,249 133,911 142,738 139,380 97,967 517,533 258,478 285,988 513,547 461,821 345,569 309,170 59,930 129,478 90,988 757,523 1,200,429 1,530,216 1,129,129 1,121,113 968,984 600,000 2,000,000 1,500,000 1,700,000 1,600,000 1,500,000 1,400,000 1,400,000 1,500,000 1,300,000 1,100,000 1,200,000 -6,500,000 1,200,000 1,200,000 1,100,000 580,000 50,000 90,000 
  operating expenses                                                                            
  research and development2,399,000 2,614,000 2,534,000 4,248,000 3,905,000 3,851,000 3,992,000 4,014,000 2,895,000 2,255,000 5,258,000 3,788,000 2,803,000 1,862,000 3,017,000 2,325,000 1,829,000 1,044,924 1,223,274 865,037 784,024 494,710 405,936 949,706 1,683,141 1,961,619 2,326,969 3,440,102 4,957,067 5,650,152 5,109,257 7,857,677 5,544,134 5,004,583 4,128,756 3,812,353 4,379,356 2,428,362 2,553,494 2,484,426 3,056,970 4,551,673 3,151,002 3,918,915 2,630,606 4,266,931 8,870,922 7,311,902 10,858,672 19,535,551 12,731,159 12,004,901 8,587,227 11,446,470 9,971,223 11,226,701 9,071,204 13,800,000 7,000,000 7,600,000 7,100,000 4,800,000 4,500,000 2,300,000 3,500,000 2,000,000 2,800,000 1,700,000 2,400,000 2,400,000 1,200,000 2,100,000 2,070,000 1,160,000 1,120,000 
  sales and marketing2,518,000 4,820,000 3,962,000 4,085,000 3,566,000 3,398,000 3,277,000 5,197,000 3,433,000 3,360,000 2,715,000 2,936,000 2,062,000 1,557,000 1,260,000 2,128,000 975,000 -10,000 
  general and administrative                                                                            
  total operating expenses5,521,000 7,701,000 5,745,000 7,755,000 4,849,000 5,520,000 5,325,000 7,582,000 5,259,000 5,423,000 5,502,000 6,171,000 5,347,000 4,085,000 4,058,000 6,667,000 7,977,000 659,245 857,623 924,780 823,092 535,097 521,907 719,898 884,339 1,022,017 911,816 2,489,947 1,551,900 1,978,982 1,706,451 2,136,764 1,497,612 1,533,615 1,786,868 1,339,150 1,260,822 1,176,391 1,337,922 1,963,410 2,092,939 1,973,210 1,748,055 1,674,517 1,627,204 2,732,640 3,170,141 4,238,340 3,791,012 4,757,711 3,898,658 3,924,098 3,234,886 3,902,421 2,873,036 3,201,378 2,697,016 1,900,000 2,200,000 2,000,000 1,900,000 1,900,000 1,400,000 1,200,000 1,300,000 2,000,000 900,000 1,200,000 700,000 1,400,000 700,000 500,000 700,000 1,080,000 460,000 470,000 
  operating income10,438,000 15,135,000 12,241,000 16,088,000 12,320,000 12,769,000 12,594,000 16,793,000 11,587,000 11,038,000 13,475,000 12,895,000 10,212,000 7,504,000 8,335,000 11,120,000 10,781,000 1,704,169 2,080,897 1,789,817 1,607,116 1,029,807 927,843 1,669,604 2,567,480 2,983,636 3,238,785 5,930,049 6,508,967 7,629,134 6,815,708 9,994,441 7,041,746 6,538,198 5,915,624 5,151,503 5,640,178 3,604,753 3,891,416 4,447,836 5,149,909 6,524,883 4,899,057 5,593,432 4,257,810 6,999,571 12,041,063 11,550,242 14,649,684 24,293,262 16,629,817 15,928,999 12,138,590 15,655,142 13,119,218 14,682,251 12,010,505 15,900,000 9,400,000 9,800,000 9,300,000 6,800,000 6,100,000 3,700,000 5,000,000 4,100,000 3,800,000 2,900,000 3,200,000 -4,300,000 3,200,000 1,800,000 2,800,000 3,150,000 1,620,000 1,580,000 
  net income-5,095,000 -9,345,000 -7,213,000 11,648,000 -6,354,000 -7,746,000 -7,290,000 -11,370,000 -6,892,000 -7,978,000 -15,597,000 -15,208,000 -18,660,000 -8,887,000 -8,771,000 -12,181,000 -10,642,000 -1,704,169 -2,059,629 -1,772,358 -1,590,856 -360,497 1,004,192 -1,660,752 1,125,687 -1,367,911 429,548 -1,954,137 -3,007,660 -3,753,742 -3,295,449 -6,123,268 -4,018,561 -2,474,453 -4,666,024 -4,572,042 -5,614,929 -3,470,842 -3,748,678 -4,308,456 -5,051,942 -6,007,350 -4,640,579 -5,307,444 -3,744,263 -6,537,750 -11,695,494 -11,241,072 -14,589,754 -24,163,784 -16,538,829 -15,171,476 -10,938,161 -14,124,926 -11,990,089 -13,561,138 -11,041,521 -15,300,000 -7,400,000 -8,300,000 -7,600,000 -5,200,000 -4,600,000 -2,300,000 -3,600,000 -2,600,000 -2,500,000 -1,800,000 -2,000,000 -2,200,000 -2,000,000 -600,000 -1,700,000 -2,570,000 -1,570,000 -1,500,000 

We provide you with 20 years income statements for CASI Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CASI Pharmaceuticals stock. Explore the full financial landscape of CASI Pharmaceuticals stock with our expertly curated income statements.

The information provided in this report about CASI Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.